For example, the combination of anti-PD-L1 antibodies with TILs has demonstrated the potential to enhance T-cell infiltration and increase the production of IFN-gamma (IFN-γ) in tumor-bearing mice, resulting in a reduction in tumor growth [171]. Here, IFNG is linked to neoplasm.